Skip to main content
logo
Acumen Pharmaceuticals, Inc. (ABOS)
NASDAQ: ABOS · Real-Time Price · USD
3.100
+0.025 (0.81%)
At close: Aug 25, 2026, 4:00 PM EDT
3.030
-0.070 (-2.26%)
After-hours: Aug 25, 2026, 7:59 PM EDT

Acumen Pharmaceuticals Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
------
Revenue Growth
------
Gross Profit
-86.79-104.89-93.8-42.32-32.36-12.31
Operating Income
-105.42-123.83-114.02-61.14-45.24-19.58
Net Income
-105.04-121.34-102.33-52.37-42.86-100.61
Earnings Per Share
-1.64-2.00-1.71-1.08-1.06-5.02
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
110.2116.87231.53306.08193.44225.86
Total Debt
31.6531.3129.731.050.11-
Net Cash (Debt)
78.5585.55201.82275.03193.34225.86
Net Cash Growth
-42.27%-57.61%-26.62%42.25%-14.40%415.92%
Net Cash Per Share
1.221.413.365.664.7611.26

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-91.79-115.54-86.22-43.06-35.15-17.96
Capital Expenditures
--0.09-0.02-0.02-0.16-0.04
Free Cash Flow
-91.79-115.63-86.23-43.09-35.31-18
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Margin
------
Profit Margin
------
FCF Margin
------

Valuation
Selected indicators aren't available for this stock.